TechKim

China Pharma Delivers on Improved Financials Promise

In addition to my comment.

The negativity has not been fully addressed in regards to the accounts receivables.

I am at least addressing the reason. I am also addressing what I believe is behind the backlog. I also believe I have relieved some of the negativity.


If you were a new investor! Would you also not want to know why this company has $24m in accounts receivables and not in the bank?

A new investor could look at the $24m as earnings of $0.60 per share or as $0.60 per share of bad debt.

I for one WANT to believe that the $24.8m in accounts receivable backlog is as good as money in the bank.